Tempus AI, Inc. (NASDAQ:TEM) COO Sells $234,803.16 in Stock

Tempus AI, Inc. (NASDAQ:TEM) COO Ryan Fukushima sold 2,868 shares of the company’s stock in a transaction on Wednesday, February 19th. The shares were sold at an average price of $81.87, for a total value of $234,803.16. Following the transaction, the chief operating officer now directly owns 944,460 shares in the company, valued at $77,322,940.20. This trade represents a 0.30 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Ryan Fukushima also recently made the following trade(s):

• On Tuesday, February 4th, Ryan Fukushima sold 20,000 shares of Tempus AI stock. The shares were sold at an average price of $62.50, for a total value of $1,250,000.00.
• On Tuesday, January 7th, Ryan Fukushima sold 20,000 shares of Tempus AI stock. The shares were sold at an average price of $39.61, for a total value of $792,200.00.
• On Monday, December 16th, Ryan Fukushima sold 3,500 shares of Tempus AI stock. The shares were sold at an average price of $40.23, for a total value of $140,805.00.
• On Wednesday, December 11th, Ryan Fukushima sold 120,000 shares of Tempus AI stock. The stock was sold at an average price of $42.51, for a total value of $5,101,200.00.

Tempus AI Price Performance

TEM opened at $68.09 on Friday. Tempus AI, Inc. has a 12-month low of $22.89 and a 12-month high of $91.45. The business has a 50 day moving average of $50.29 and a 200-day moving average of $51.72. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17.

Institutional Trading of Tempus AI

A number of hedge funds have recently made changes to their positions in the business. Operose Advisors LLC acquired a new stake in Tempus AI during the 4th quarter worth approximately $25,000. First Horizon Advisors Inc. bought a new position in shares of Tempus AI in the 3rd quarter valued at $30,000. Farther Finance Advisors LLC bought a new position in shares of Tempus AI in the 4th quarter valued at $34,000. Prestige Wealth Management Group LLC increased its stake in shares of Tempus AI by 910.4% in the 4th quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company’s stock valued at $36,000 after purchasing an additional 965 shares during the last quarter. Finally, NewEdge Advisors LLC bought a new position in shares of Tempus AI in the 4th quarter valued at $49,000. 24.22% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on TEM. Loop Capital lowered their price target on Tempus AI from $57.00 to $52.00 and set a “buy” rating for the company in a report on Tuesday, January 14th. Guggenheim initiated coverage on Tempus AI in a report on Monday, December 9th. They set a “buy” rating and a $74.00 price objective for the company. Bank of America increased their price objective on Tempus AI from $52.00 to $54.00 and gave the stock a “neutral” rating in a report on Friday, December 13th. Needham & Company LLC reiterated a “buy” rating and set a $56.00 price objective on shares of Tempus AI in a report on Tuesday, January 14th. Finally, TD Cowen restated a “buy” rating and issued a $74.00 price target (up from $58.00) on shares of Tempus AI in a research note on Wednesday, February 5th. Four analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $58.55.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.